Cite
HARVARD Citation
de Jong, J. et al. (2018). A drug–drug interaction study of ibrutinib with moderate/strong CYP3A inhibitors in patients with B-cell malignancies. Leukemia & lymphoma. 59 (12), pp. 2888-2895. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
de Jong, J. et al. (2018). A drug–drug interaction study of ibrutinib with moderate/strong CYP3A inhibitors in patients with B-cell malignancies. Leukemia & lymphoma. 59 (12), pp. 2888-2895. [Online].